Sebaceous hyperplasia is a harmless overgrowth of the sebaceous (oil) gland. The Pilosebaceous follicle otherwise referred to as pores, have an oil gland (sebaceous gland) attached which is not usually visible as it lies beneath the skin’s surface. When an overgrowth of the Sebaceous gland develops, small bumps become visible around the opening of the pore. Each sebaceous hyperplasia can vary slightly in size (2-9mm), shape, they often appear raised but usually circular displaying a soft or firm white, beige or yellowish outer rim with a depressed centre (pore opening). It’s not known why Sebaceous hyperplasia occurs, however they are more prevalent in middle aged people prone to rosacea and those with an oily skin condition. Approximately 10–16% of people on long-term cyclosporin A for organ transplants also develop Sebaceous hyperplasia.
Sebaceous hyperplasia is often mistaken by clients to be milia. Sebaceous hyperplasia can be unsightly and can easily be removed with treatment.
Lesions may be single or multiple. They are seen in areas where many oil glands are found – the face (nose, cheeks, and forehead), chest, upper arms, mouth lining, vulvar area, and around the nipples.
Call Now For a FREE Assessment (03) 8686 5786
Cosmetic management of Seborrheic hyperplasia papules involves treatment with fine needle diathermy or laser treatment which precisely targets the lesions. Treatment addresses the problem by cauterising, flattening and removing the papular growths, leaving a smoother, clearer complexion.
Improvement of Rosacea and Seborrheic skin conditions with laser and cosmeceutical treatment assists in the maintenance program following removal.
Mild inflammation and mild crusting can be expected following treatment. Healing is generally fast and complete without scarring. Post care involves a healing ointment for a few days. Depending on the number of Seborrheic Hyperplasia papules present will determine whether a single treatment is sufficient to remove them or whether several treatment sessions need to be scheduled.